FOUNDED IN 2014, CELLphenomics GMBH IS AN INNOVATIVE BIOTECH COMPANY BASED IN BERLIN, GERMANY, SPECIALIZED IN DEVELOPING SOPHISTICATED 3D CANCER MODELS
We at CELLphenomics believe in a phenomic approach to develop novel cancer treatments that put an end to relapse and metastasis.
We partner with pharmaceutical and biotech companies to help accelerating the early drug discovery process with enhanced biological relevance assays through patient-derived 3D-based cell cultures. Using state-of-the-art 3D tumor cell models, scientists at CELLphenomics conduct rigorous analysis to push the boundaries in early stage drug screening. CELLphenomics‘ has also developed a revolutionary and innovative drug-screening approach for patients that makes 3D testing a reliable companion in decision making.
With over 40 years combined experience in molecular and cellular oncology, CELLphenomics‘ goal is to help you accelerate treatments that put an end to cancer relapse.
CELLphenomics is expanding and we are always looking for strategic partnerships to help us bring novel treatments to cancer patients. If you are interested in learning how your business can take advantage of our technology, or if you would like to learn more about how you can invest in our mission, please contact us today.